Q3 2017 Holdings
Filed 2017-11-09 | 131 holdings | $700.9K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2017-11-27) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $121.2K | 1,400,000 | 17.3% |
| Celgene Corp(CELG) | COM | 151020104 | $40.1K | 275,000 | 5.7% |
| Biogen Inc(BIIB)A | COM | 09062X103 | $32.9K | 105,000 | 4.7% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $27.2K | 425,000 | 3.9% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $18.6K | 230,000 | 2.7% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $18.3K | 450,000 | 2.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $17.5K | 384,997 | 2.5% |
| Cellcom Israel LTD(CEL) | SHS | M2196U109 | $14.3K | 1,535,988 | 2.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $13.9K | 390,000 | 2.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $13.2K | 86,500 | 1.9% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $13.0K | 158,000 | 1.9% |
| Allergan PLC | SHS | G0177J108 | $12.3K | 60,000 | 1.8% |
| Tesaro Inc | COM | 881569107 | $10.3K | 80,000 | 1.5% |
| Cellectis S A(CLLS)A | SPONSORED ADS | 15117K103 | $9.9K | 348,736 | 1.4% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $8.9K | 109,159 | 1.3% |
| Ituran Location and Control(ITRN) | SHS | M6158M104 | $8.3K | 229,283 | 1.2% |
| Biomarin Pharmaceutical Inc(BMRN)A | COM | 09061G101 | $7.9K | 85,000 | 1.1% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $7.8K | 145,000 | 1.1% |
| Aldeyra Therapeutics Inc(ALDX)A | COM | 01438T106 | $7.5K | 1,044,131 | 1.1% |
| Orbotech LTD | ORD | M75253100 | $7.4K | 175,243 | 1.1% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADR | 881624209 | $7.0K | 400,000 | 1.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $7.0K | 129,779 | 1.0% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $6.8K | 150,000 | 1.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $6.4K | 205,000 | 0.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $6.3K | 420,000 | 0.9% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $6.3K | 450,000 | 0.9% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $5.8K | 1,000,000 | 0.8% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $5.7K | 520,269 | 0.8% |
| Ignyta Inc | COM | 451731103 | $5.7K | 459,300 | 0.8% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $5.6K | 5,767 | 0.8% |
| Visa Inc(V) | COM CL A | 92826C839 | $5.6K | 52,951 | 0.8% |
| Facebook Inc(META) | CL A | 30303M102 | $5.5K | 32,167 | 0.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $5.3K | 87,000 | 0.8% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $5.2K | 150,000 | 0.7% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $5.1K | 1,400,000 | 0.7% |
| Zogenix Inc | COM NEW | 98978L204 | $5.1K | 145,000 | 0.7% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $5.0K | 405,000 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $4.9K | 526,315 | 0.7% |
| Charter Communications Inc N(CHTR)A | CL A | 16119P108 | $4.9K | 13,362 | 0.7% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $4.8K | 625,000 | 0.7% |
| Mylan N VCall | SHS EURO | N59465109 | $4.7K | 150,000 | 0.7% |
| Ascendis Pharma A S(ASND)A | SPONSORED ADR | 04351P101 | $4.7K | 129,474 | 0.7% |
| Sapiens Intl Corp N V | SHS NEW | N7716A151 | $4.7K | 354,866 | 0.7% |
| Retrophin Inc | COM | 761299106 | $4.3K | 174,131 | 0.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.2K | 135,000 | 0.6% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $4.2K | 228,534 | 0.6% |
| Teva Pharmaceutical FIN LLC | DBCV 0.250% 2/0 | 88163VAE9 | $4.1K | 11,885 | 0.6% |
| Spdr Gold Trust(GLD) | GOLD SHS | 78463V107 | $4.0K | 33,190 | 0.6% |
| Global Blood Therapeutics in | COM | 37890U108 | $3.9K | 127,000 | 0.6% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $3.9K | 60,000 | 0.6% |